Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 57 filings.
12 Aug 2026 1 filing
Dividend record date
Record date for dividend FY 2025-26 fixed for closing hours on 17 September 2026.
11 Aug 2026 3 filings
Overview
Unaudited standalone and consolidated Q1 FY27 results for quarter ended 30 June 2026.
Financial highlights
Q1 FY27 revenue ₹784.17 crore, up 68% YoY.
Q1 FY27 EBITDA ₹124.84 crore.
Q1 FY27 PBT before Exceptional Item ₹103.65 crore.
Q1 FY27 PBT ₹103.65 crore; PAT ₹77.82 crore.
Q4 FY26 revenue ₹125.59 crore, EBITDA ₹20.31 crore.
Q4 FY26 PBT ₹7.73 crore; PAT ₹5.83 crore.
Q4 FY26 exceptional item income ₹7.62 crore.
Operational & governance updates
Planned Q4 FY26 shutdown for expansion project.
AGM scheduled for 25 September 2026 at 2:00 PM IST via video conference.
Geopolitical tensions raised input costs, but lower import pressures supported performance.
Leadership noted strong quarter due to cost-led efficiencies and capacity utilization.
Board outcomes
Unaudited standalone and consolidated Q1 2026-27 results filed with Limited Review Report.
41st AGM scheduled for 25 September 2026 at 2:00 PM via VC/OVAM.
Dividend of ₹1.50 per equity share for FY2025-26, subject to AGM approval.
Record dates: physical 25 Sep 2026; electronic 17 Sep 2026; register closes 18–25 Sep 2026.
Appointment of Mr. Sanket Balvantrao Waghe, IAS, as Additional Director (Non-Executive Non-Independent) effective 11 Aug 2026.
Cost Auditors appointed for FY 2026-27: M/s BY & Associates, Chennai.
Annexures detailing appointments provided; available on the company's website.
Financial Highlights
Standalone quarter revenue from operations ₹77,792 lakh; total income ₹78,417 lakh.
Standalone net profit after tax ₹7,782 lakh; EPS Basic ₹8.65.
Consolidated quarter revenue from operations ₹77,792 lakh; total income ₹78,686 lakh.
Consolidated net profit after tax ₹8,011 lakh; EPS ₹8.90.
Single operating segment: Manufacturing of Industrial Intermediate Chemicals.
Land lease expiry noted; renewal awaited; ROA accounting under renewal period.
Shutdown for LAB and HCD expansion Jan–Mar 2026; last quarter FY25-26 not comparable.
Independent auditor's review: no material misstatement.
Quarter ended 30-Jun-2026; results approved 11 Aug 2026.
10 Aug 2026 1 filing
Director Resignation
Sweta Suman, IAS, Non-Executive & Non-Independent Director, resigned effective 10 August 2026 due to withdrawal of TIDCO nomination.
13 Jul 2026 1 filing
Cessation: Sandhya Venugopal Sharma
Sandhya Venugopal Sharma, IAS, Chairperson and Non-Executive Director, resigned effective 13 July 2026 due to TIDCO nomination withdrawal.